未登录

Z

Zhencong Chen

fudan university

H指数:24

被引数:1,803

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dissection of the cell communication interactions in lung adenocarcinoma identified a prognostic model with immunotherapy efficacy assessment and a potential therapeutic candidate gene ITGB1

IF3.6

2024-09-010

OAAI

Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer

NATURE COMMUNICATIONS

IF15.7

2024-03-1917

OAAI

MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma

MAFF通过调节肺腺癌的铁死亡和细胞周期进程，赋予基于顺铂和电离辐射治疗的脆弱性

DRUG RESISTANCE UPDATES

IF21.7

2024-03-019

PRE

IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2024-02-2913

OAAI

Transcription factor ZNF263 enhances EGFR-targeted therapeutic response and reduces residual disease in lung adenocarcinoma

IF6.9

2024-02-017

OA

Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma

IF10.1

2024-01-016

PRE

Lobe-Specific Lymph Node Dissection May be Feasible for Clinical N0 Solid-Predominant Part-Solid Lung Adenocarcinoma With Solid Component Diameter ≤ 2 cm

CLINICAL LUNG CANCER

IF3.3

2023-07-012

PRE

Retinol Saturase Mediates Retinoid Metabolism to Impair a Ferroptosis Defense System in Cancer Cells

CANCER RESEARCH

IF16.6

2023-05-1515

OA

Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma

解剖巨噬细胞的单细胞转录组网络并鉴定预测肺腺癌预后的特征

CELLULAR ONCOLOGY

IF4.8

2023-04-2011

OAAI

Identification and validation of the mitochondrial function related hub genes by unsupervised machine learning and multi-omics analyses in lung adenocarcinoma

IF3.6

2022-12-013

OAAI

FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis

FSCN1诱导PTPRF依赖的肿瘤微环境炎症重编程通过调控巨噬细胞糖酵解促进肺腺癌进展

CELLULAR ONCOLOGY

IF4.8

2022-10-129

PRE

miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways

MOLECULAR THERAPY NUCLEIC ACIDS

IF6.1

2022-06-0167

OAAI

Cisplatin resistance-related multi-omics differences and the establishment of machine learning models

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2022-04-1133

OAAI

Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2

多组学分析确定了具有KEAP1/NFE2L2的肺腺癌中具有临床相关性的不同亚型

JOURNAL OF CANCER

IF3.2

2022-01-010

OAAI

HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2021-12-2043

OAAI

Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy

IF6.4

2021-10-2632

OAAI

Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma

IF10.8

2021-07-0174

OAAI

The tumor environment immune phenotype of LUSC by genome-wide analysis

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2021-07-016

OAAI

Integrative genome-scale analysis of immune infiltration in esophageal carcinoma

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2021-04-015

PREAI

Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma

早期和晚期肺腺癌中单个肿瘤和免疫细胞的景观和动态

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2021-03-0966

OAAI